A small boutique landed a lucrative lead role on the $8.7 billion Novartis-AveXis deal
04/09/2018 General World News
Suarez Celebration

  • Dyal Co., a small M&A boutique, landed a lead role on the the $8.7 billion Novartis-AveXis deal.
  • The firm has roughly 15 employees and is led by ex-Goldman Sachs rainmaker Gordon Dyal.
  • Dyal was the former co-chairman of investment banking at Goldman, where he spent years leading M&A deals in Europe.
  • He’s leveraged that experience to land advisory roles with multinational companies since starting his own firm.

Novartis on Monday announced its $8.7 billion acquisition of gene-therapy firm AveXis, which could add billions in new revenue for the Swiss drugmaker.

The deal is expected to close in the middle of this read more >>>

Source:: BusinessInsider.Com

Comments are closed
BusinessMediaguide.Com Independent, Global Business Media Network © 2018. ALL RIGHTS RESERVED. BusinessMediaguide.Com is not responsible for the content of external sites!... Beta...

Privacy policy